Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Denosumab Versus Oral Bisphosphonate (Alendronate) for Osteoporosis in Long-term Glucocorticoid Users: an Open Randomized Controlled Trial

NCT03005678 is registered in ClinicalTrials.gov with Tuen Mun Hospital as lead sponsor.

NCT NCT03005678
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03005678 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Denosumab Versus Oral Bisphosphonate (Alendronate) for Osteoporosis in Long-term Glucocorticoid Users: an Open Randomized Controlled Trial
Lead sponsor
Tuen Mun Hospital
Phase
Phase 4
Overall status
Completed
Start date
April 1, 2017
Completion date
February 1, 2020
Enrollment
140 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

osteoporosis